
Serum Institute of India, the world’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis vaccine VPM1002 is effective as a preventive and immunity booster vaccine against Covid-19.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2wzHZD2
via
IFTTT
0 comments:
Post a Comment